These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 6462571

  • 61. Neoadjuvant intraarterial infusion chemotherapy in patients with stage IB2-IIIB cervical cancer.
    Yamakawa Y, Fujimura M, Hidaka T, Hori S, Saito S.
    Gynecol Oncol; 2000 May; 77(2):264-70. PubMed ID: 10785476
    [Abstract] [Full Text] [Related]

  • 62. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA, Tewari KS, Shah A, Brewster WR, Burger RA, Kuo JV, Monk BJ.
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [Abstract] [Full Text] [Related]

  • 63. [Pretherapeutic chemosensitivity testing of ovarian cancer and possibilities for its clinical use].
    Hernádi Z, Pásti G, Lampé L, Juhász B.
    Zentralbl Gynakol; 1985 Jan; 107(17):1065-71. PubMed ID: 4060913
    [Abstract] [Full Text] [Related]

  • 64. New drugs in ovarian cancer and malignant melanoma: in vitro phase II screening with the human tumor stem cell assay.
    Salmon SE, Meyskens FL, Alberts DS, Soehnlen B, Young L.
    Cancer Treat Rep; 1981 Jan; 65(1-2):1-12. PubMed ID: 7226159
    [Abstract] [Full Text] [Related]

  • 65. Use of a human tumor cloning system to evaluate analogs of methotrexate and mitoxantrone.
    Lathan B, Von Hoff DD, Elslager E.
    Cancer Treat Rep; 1984 May; 68(5):733-8. PubMed ID: 6233003
    [Abstract] [Full Text] [Related]

  • 66. [In vitro chemosensitivity of various human tumors evaluated by the SDI (succinate dehydrogenase inhibition) test].
    Maehara Y, Anai H, Masuda H, Tamada R, Sugimachi K, Inokuchi K.
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):2018-23. PubMed ID: 4051518
    [Abstract] [Full Text] [Related]

  • 67. Patterns of radiotherapy practice for patients with carcinoma of the uterine cervix: a patterns of care study.
    Eifel PJ, Moughan J, Erickson B, Iarocci T, Grant D, Owen J.
    Int J Radiat Oncol Biol Phys; 2004 Nov 15; 60(4):1144-53. PubMed ID: 15519786
    [Abstract] [Full Text] [Related]

  • 68. [An in vitro chemosensitivity study using the human tumor clonogenic assay in urological malignancies: a preliminary report].
    Uchibayashi T, Hisazumi H, Asari T, Kobashi K, Amano T, Naito K.
    Hinyokika Kiyo; 1987 Oct 15; 33(10):1575-80. PubMed ID: 3445845
    [Abstract] [Full Text] [Related]

  • 69. Comparison of in vitro drug sensitivity by inhibition of tritium release from [5-3H]-2'-deoxyuridine and a clonogenic assay.
    Aschele C, Romanini A, Nicolin A, Rosso R, Sobrero A.
    Anticancer Res; 1990 Oct 15; 10(3):759-64. PubMed ID: 2195987
    [Abstract] [Full Text] [Related]

  • 70. [Significance of formation of micronuclei in SCC VII murine cells treated with various chemotherapeutic agents].
    Jeremić B, Sibamoto J, Abe M.
    Srp Arh Celok Lek; 1996 Oct 15; 124(7-8):169-74. PubMed ID: 9102841
    [Abstract] [Full Text] [Related]

  • 71. Are increased tumor aneuploidy and heightened cell proliferation along with heterogeneity associated with patient outcome for carcinomas of the uterine cervix? A combined analysis of subjects treated in RTOG 9001 and a single-institution trial.
    Wolfson AH, Winter K, Crook W, Krishan A, Grigsby PW, Markoe AM, Morris M, Gaffney DK, Eifel PJ, Lucci JA.
    Int J Radiat Oncol Biol Phys; 2008 Jan 01; 70(1):111-7. PubMed ID: 17919835
    [Abstract] [Full Text] [Related]

  • 72. Prevalence of in vitro extreme chemotherapy resistance in resected nonsmall-cell lung cancer.
    d'Amato TA, Landreneau RJ, McKenna RJ, Santos RS, Parker RJ.
    Ann Thorac Surg; 2006 Feb 01; 81(2):440-6; discussion 446-7. PubMed ID: 16427828
    [Abstract] [Full Text] [Related]

  • 73. Selective enhancement by menadiol of in vitro drug activity in human lymphatic neoplasms.
    Su YZ, Duarte TE, Dill PL, Weisenthal LM.
    Cancer Treat Rep; 1987 Jun 01; 71(6):619-25. PubMed ID: 3581100
    [Abstract] [Full Text] [Related]

  • 74. Enhancement of cisplatin induced apoptosis by suberoylanilide hydroxamic acid in human oral squamous cell carcinoma cell lines.
    Shen J, Huang C, Jiang L, Gao F, Wang Z, Zhang Y, Bai J, Zhou H, Chen Q.
    Biochem Pharmacol; 2007 Jun 15; 73(12):1901-9. PubMed ID: 17445779
    [Abstract] [Full Text] [Related]

  • 75. [Progress in experimental chemotherapy of colorectal cancer].
    Scheithauer W.
    Acta Med Austriaca; 1987 Jun 15; 14(5):118-24. PubMed ID: 3439421
    [Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77. [Flow cytometric studies of brain tumors--5: New sensitivity test of antineoplastic agents for brain tumors and its clinical application].
    Kawakami K, Kawamoto K, Oka N, Kawamura Y, Matsumura H, Ito T, Ohyama A.
    No Shinkei Geka; 1986 Apr 15; 14(5):627-34. PubMed ID: 2425281
    [Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80. [Pretherapeutic testing of cytostatic drugs in head and neck cancers].
    Wustrow TP, Valet G.
    Laryngol Rhinol Otol (Stuttg); 1987 Sep 15; 66(9):451-6. PubMed ID: 3683037
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.